BioSpace News Archive

Deals

Calliditas Therapeutics: Interim Report Q1, 2019

This first quarter of 2019, we were busy ensuring that the recruitment efforts for our pivotal phase 3 study NefIgArd remain on track, focusing on site initiation visits and supporting our CRO in their work to ensure that all sites are brought online on a timely manner.

May 8, 2019
·
3 min read
Drug Development

AAN 2019: Two New Analyses of Lasmiditan Phase 3 Studies Measured Onset of Effect and the Effect of Lasmiditan in Patients with Prior Triptan Experience

The lasmiditan Phase 3 program encompassed more than 4,000 patients and 20,000 migraine attacks

May 8, 2019
·
11 min read
Deals

Hill-Rom Declares Fiscal 2019 Third Quarter Dividend

Hill-Rom Holdings, Inc., announced that its board of directors declared a fiscal 2019 third quarter dividend of $0.21 per share payable on June 28, 2019, to shareholders of record as of the close of business on June 21, 2019.

May 8, 2019
·
1 min read
Business

Clarkston Consulting Announces Its Participation at SAPPHIRE NOW® to Showcase Use of Settlement Management and Combined CO-PA for Gross-to-Net Revenue Analysis

Clarkston Consulting announced that it will participate at SAPPHIRE NOW® and ASUG Annual Conference being held May 7-9 in Orlando, Florida in booth #1234.

May 8, 2019
·
3 min read
Drug Development

MaxCyte Progresses Phase I Clinical Trial of Lead mRNA-based Cell Therapy from its CARMA™ Platform

No dose-limiting toxicities or safety concerns observed in first cohort of treated patients

May 8, 2019
·
4 min read
BioCapital

REGENXBIO to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference

REGENXBIO Inc. announced it will present at the Bank of America Merrill Lynch 2019 Healthcare Conference on Wednesday, May 15, 2019, at the Encore Wynn Hotel, Las Vegas, NV:

May 8, 2019
·
1 min read
Deals

The Green Organic Dutchman Enters US Market Through Cornerstone Investment in Califormulations LLC

The Green Organic Dutchman Holdings Ltd. is pleased to announce the Company’s strategic investment into the US beverage space as a co-founding investor and strategic partner in the newly formed Califormulations LLC.

May 8, 2019
·
6 min read
Business

TherapeuticsMD Announces Participation at the Bank of America Merrill Lynch 2019 Health Care Conference

TherapeuticsMD, Inc. announced that the company will participate in the Bank of America Merrill Lynch 2019 Health Care Conference.

May 8, 2019
·
3 min read
Business

Moderna Reports First Quarter 2019 Financial Results and Provides Business Updates

Rare Diseases: New development candidate announced for glycogen storage disease type 1a (GSD1a), a rare metabolic disorder; Company now has five rare disease programs in its pipeline

May 8, 2019
·
18 min read
Deals

BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio

BioNTech SE announced the acquisition of antibody assets and infrastructure from San Diego-based MabVax Therapeutics Holding, Inc., a clinical-stage oncology drug development company.

May 8, 2019
·
3 min read